APRIL inhibition

搜索文档
Climb Bio (NasdaqGM:CLYM) Update / Briefing Transcript
2025-09-29 13:02
Climb Bio (NasdaqGM:CLYM) Update / Briefing September 29, 2025 08:00 AM ET Company ParticipantsCarlo Tanzi - Principal & FounderAoife Brennan - President, CEO & Board MemberCraig Gordon - Nephrologist & Co-Director of Evidence ReviewEdgar Charles - Chief Medical OfficerJulian Harrison - Managing DirectorMatt Phipps - Group Head - BiotechnologyConference Call ParticipantsColleen Kusy - Senior Research Analyst - BiotechnologyThomas Smith - Senior MD & Senior Research AnalystLeland Gershell - MD & Senior Biote ...